$29.62
0.000.00%
Pre-Market: Dec 24, 1:00 PM EDT
Comments
Loading...
Edgewise Therapeutics (EWTX) Forecast
NewsEarningsEdgewise Therapeutics (EWTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdgewise Therapeutics (NASDAQ:EWTX) Stock Quotes, Forecast and News Summary
Edgewise Therapeutics Stock (NASDAQ: EWTX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Edgewise Therapeutics (EWTX) stock?
You can purchase shares of Edgewise Therapeutics (NASDAQ:EWTX) through any online brokerage.
Who are Edgewise Therapeutics (EWTX) competitors?
Other companies in Edgewise Therapeutics’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).
What is the forecast, or price target, for Edgewise Therapeutics (EWTX) stock?
Edgewise Therapeutics has a consensus price target of $38.00.
What is the current price for Edgewise Therapeutics (EWTX)?
The stock price for Edgewise Therapeutics (NASDAQ: EWTX) is $29.62 last updated December 24, 2024 at 1:00 PM EST.
Does Edgewise Therapeutics (EWTX) pay a dividend?
There are no upcoming dividends for Edgewise Therapeutics.
When is Edgewise Therapeutics (NASDAQ:EWTX) reporting earnings?
Edgewise Therapeutics’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is Edgewise Therapeutics (EWTX) going to split?
There is no upcoming split for Edgewise Therapeutics.
What sector and industry does Edgewise Therapeutics (EWTX) operate in?
Edgewise Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.